Major Pharmaceutical Markets of the Middle East An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE

Summary

Major Pharmaceutical Markets of the Middle East is a comprehensive report providing extensive coverage of one of the strongest emerging markets. Through quality analysis and forecasts, this unique report will allow you to identify market trends and growth potential opportunities.

The report provides the necessary background information for a firm to operate in the region.

Chapter summaries:

Chapter 1: covers the main characteristics of the Middle Eastern market through a Political, Economic, Social and Technological (PEST) analysis, plus insight into the tax environment and Free-Trade Agreements in place or being negotiated.

Chapter 2: reports on the Intellectual Property Rights environment of each of the countries covered.

Chapter 3: provides a overview of the regional pharmaceutical market, and includes data on consumption, production, imports, exports, as well as market forecasts.

The other chapters are in-depth per-country market studies.

Country coverage

Egypt, the largest pharmaceutical market of the region

Israel, home to the world's largest generic drug company

Jordan, the leading Arab pharmaceutical exporter

Lebanon, an almost exclusive import market

Saudi Arabia, the largest market of the Gulf

The United Arab Emirates, among the highest-priced markets in the region

Five key findings

The Middle East market has achieved impressive growth to reach $8bn worth in 2005. The regional pharmaceutical Combined Annual Growth Rate (CAGR) between 1999-2003 was second only to Southeast Asia and China.

The Middle East is a high-import market. Israel, Jordan, Saudi Arabia and Lebanon import respectively 60%, 70%, 80% and 94% of their pharmaceutical needs.

Local manufacturing capabilities are constrained to generics.

A high acceptance of Western medicines is present

Generics have a low market penetration as most countries apart from Egypt are considered brand-name countries.

What you can learn from this report

- Which multinationals have invested in the Middle East

- Who are the leading local pharmaceutical manufacturers and distributors

- What are the trends in the pharmaceutical market and import and export sizes

- How Intellectual Property Rights and patents are the most conflictual regional issue

- Which countries have implemented health insurance and the likely impact on growth

- What type of demand and supply-side cost controls are in place

Reasons to purchase the report

- Five-year projected sales figure to enable proprietary forecasting

- Detailed Political, Economic, Social and Technological (PEST) analysis providing thorough regional and country background

- Extensive list of local contacts to facilitate finding a potential business partner

- Thorough review of country pharmaceutical markets using latest available data

- Researched by a native speaker using primary and secondary data

Who should buy the report?

- Chief Executive Officers

- Marketing Directors

- Sales Directors

- Finance Directors

- Head of Commercial Strategy

- Head of Forecasting Unit

- Banking Analysts

- Consultants

Title Major Pharmaceutical Markets of the Middle East

Sub title An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE

Author JM Saliba

Publication date April 2006

Pages 100

Format: PDF
Table of Contenst
Executive Summary
Price: $1,645.00 / GBP822.50